FindTrial
Sign In

To Study Post Covid Symptoms

Prevalence of Long Haul Covid In General Population - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2023/07/055278
Enrollment
50
Registered
2023-07-17
Start date
Unknown
Completion date
Unknown
Last updated
2023-07-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: U071- COVID 19 virus identified

Interventions

Intervention1: Nil: Nil Control Intervention1: Nil: Nil

Sponsors

Dr Mahesh Saini
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Whoever give verbal consent for study. 2. Had covid at least 3 months prior to study.

Exclusion criteria

Exclusion criteria: Having covid infection within 3 months of study.

Design outcomes

Primary

MeasureTime frame
1. To determine the diseases prevailing in society due to long covid. 2. Information is lacking on symptoms that persist after recovery from Covid-19. We will asses persistent symptoms in patients who recoverd from COVID-19.Timepoint: 2 weeks, 4 weeks, 6 weeks—

Secondary

MeasureTime frame
1. Early diagnosis of diseases which are present in other covid 19 patients.Timepoint: 2 weeks, 4 weeks, 6 weeks—

Countries

India

Contacts

Public ContactDr Mahesh Saini

Varun Arjun Medical College And Rohilkhand Hospital

maheshgazanfarmedicine@gmail.com9419488172

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026